Skip to main content
Fig. 3 | European Journal of Medical Research

Fig. 3

From: Development and validation of an individualized gene expression-based signature to predict overall survival of patients with high-grade serous ovarian carcinoma

Fig. 3

Identification of robust prognostic factors. A The frequency of genes in five thousand lasso regressions. B The difference in the expression distribution of the two genes in Cluster1 and Cluster2. C 1, 3and 5 years AUC of ROC of AKR1B10. D KM survival curve of high expression of AKR1B10 group and low expression of AKR1B10 group. E 1-, 3-, and 5- years AUC of ROC of ANGPT4. F: KM survival curve of high expression of ANGPT4 group and low expression of ANGPT4 group

Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us